Today: 21 May 2026
Blackstone stock closes higher as Barclays trims target; CPI and earnings loom
10 January 2026
2 mins read

Blackstone stock closes higher as Barclays trims target; CPI and earnings loom

NEW YORK, Jan 10, 2026, 17:06 EST — Market closed

  • Shares of Blackstone climbed 1.5% on Friday, closing at $157.62
  • Barclays lowered its price target for Blackstone to $171 but maintained an “equal weight” rating
  • Investors are focused on the U.S. CPI release set for Jan. 13 and Blackstone’s earnings report due Jan. 29

Blackstone Inc (BX.N) shares climbed 1.5% on Friday, closing at $157.62 after fluctuating between $154 and $158.26 during the session. Barclays cut its price target slightly to $171 from $172 but maintained an “equal weight” rating, signaling a neutral stance on the stock.

This shift is significant since Blackstone operates where markets meet dealmaking. Once stocks and credit stabilize, exits become smoother and fundraising usually picks up.

Timing plays a role too. Investors are aligning macro data with the kickoff of earnings season, hunting for any rate fluctuations that might shake valuations in private equity, real estate, and credit.

U.S. stock indexes hit record highs on Friday following data that revealed December job gains fell short of expectations, while the unemployment rate slipped to 4.4%, Reuters reported. Investors kept an eye on the U.S. Supreme Court’s tariff case, with new rulings anticipated on Jan. 14, according to the report. “Payrolls were a little bit light relative to consensus, but still fairly strong,” said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder.

Peers closed the session split, highlighting selective money flows within the group. KKR rose 0.7%, Carlyle climbed 1.1%, while Apollo dipped 0.2%.

Outside of BX’s own trades, Blackstone continues to unload shares steadily. Legence confirmed that underwriters fully exercised the over-allotment option—a “greenshoe” allowing banks to sell extra shares when demand is strong—linked to a secondary offering by Blackstone-affiliated sellers. This option added 1,260,326 Legence shares, priced at $45 apiece. Legence made clear it didn’t sell any stock itself or receive proceeds from this. Stock Titan

Despite Friday’s rebound, Blackstone’s share price still sits roughly 17% under its 52-week peak of $190.09. Volume for the session came in below the stock’s 50-day average, according to MarketWatch data.

Tuesday brings the U.S. consumer price index for December at 8:30 a.m. ET, a data point that could swiftly alter expectations around rate cuts. The Federal Reserve’s next policy meeting is scheduled for Jan. 27-28.

Blackstone is set to release its fourth-quarter and full-year 2025 results on Jan. 29 at 9:00 a.m. ET. Investors are eager for updates on fundraising, asset sales, and fee-related earnings, along with any change in management’s tone on deploying capital into private credit and real estate.

There are a few sharp edges in the setup. On Friday, the U.S. Supreme Court chose not to rule on the legality of President Donald Trump’s broad tariffs, leaving investors in limbo. At the same time, U.S. stock valuations remain elevated as earnings season approaches, Reuters reported.

Blackstone’s focus shifts to Monday’s reopening, with the CPI report due Jan. 13 next on the radar. After that, all eyes will be on the earnings call scheduled for Jan. 29.

Stock Market Today

  • Analyst Revises MongoDB Outlook After Sharp 22% Stock Decline
    May 20, 2026, 11:08 PM EDT. An analyst shifted to a more favorable view on MongoDB (NASDAQ: MDB) after its stock plunged 22% on March 3, 2026, despite better-than-expected fiscal Q4 results. The company reported $695 million revenue, up 27% year-over-year, with Atlas cloud revenue hitting a $2 billion annual run rate. However, cautious fiscal 2027 guidance projecting 16-18% revenue growth-below expectations-triggered the drop and a Baird price target cut from $500 to $260. The analyst now highlights MongoDB's strong business fundamentals, including a 23% adjusted operating margin and leading position in document databases, which support cloud-native applications. The initial high valuation and AI premium correction have shifted risk perceptions, revealing a steadier business amid recent market volatility.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut
Previous Story

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut

Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week
Next Story

Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week

Go toTop